This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Fluffy Unicorn (2017-08-03)

Starting date:
August 3, 2017
Posting date:
August 9, 2017
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-64192

Reason

Product sold without market authorization (NPN) in Canada. Product contains undeclared synephrine that in combination with caffeine may pose a risk to health.

Depth of distribution

Retailers

Affected products

Fluffy Unicorn

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Powder

Strength

500mg (4-Amynobutyl) guanidinium sulphate
200mg 1,3,7-Trimethylxanthine
2300mg 2-aminoethanesulfonic acid
5000mg Citrulline malate
1000mg Glycine, N- (aminoiminoMethyl) -N-Methyl-, monohydrochloride

Lot or serial number

All Lots

Companies

Recalling Firm
Distribution Limitless
8705 Rue Magloire-Lavallée
Mirabel
J7N OX9
Quebec
CANADA
Marketing Authorization Holder
Not Applicable

Date modified: